Physician Wealth Advisors’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.92K Buy
215
+64
+42% +$1.03K ﹤0.01% 1378
2026
Q2
$3.1K Hold
151
– – ﹤0.01% 1313
2026
Q1
$3.33K Hold
151
– – ﹤0.01% 1138
2025
Q4
$1.78K Buy
151
+42
+39% +$539 ﹤0.01% 1342
2025
Q3
$1.73K Hold
109
– – ﹤0.01% 1294
2025
Q2
$1.25K Buy
109
+99
+990% +$1.12K ﹤0.01% 1249
2025
Q1
$136 Hold
10
– – ﹤0.01% 1405
2024
Q4
$169 Buy
+10
New +$195 ﹤0.01% 1121

Other funds holding CC

Physician Wealth Advisors's CC Position: Q3 2026 in Review

Physician Wealth Advisors increased its Chemours (CC) stake by 42% in Q3 2026, buying an estimated $1.03K and bringing the position to 215 shares worth $2.92K. The position accounts for ﹤0.01% of the portfolio, ranked #1378.

Physician Wealth Advisors first reported a position in CC in Q4 2024 and has held it in 8 quarters since. The position peaked at $3.33K in Q1 2026. 360 funds tracked by Wall St. Rank hold CC as of Q3 2026.

  • Physician Wealth Advisors held 215 shares of Chemours worth $2.92K as of Q3 2026.
  • Physician Wealth Advisors bought 64 Chemours shares in Q3 2026, an estimated $1.03K.
  • Chemours made up ﹤0.01% of Physician Wealth Advisors's portfolio in Q3 2026, its #1378 holding.
  • Physician Wealth Advisors first reported a position in Chemours in Q4 2024 and has held it in 8 quarters since.
  • Physician Wealth Advisors's Chemours position peaked at $3.33K in Q1 2026.
  • 360 funds tracked by Wall St. Rank held Chemours as of Q3 2026.

Based on Physician Wealth Advisors's 13F filing for Q3 2026, filed 20 Oct 2026.